Chiron Capital Management LLC Has $7.12 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

Chiron Capital Management LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,084 shares of the exchange traded fund’s stock after selling 8,254 shares during the quarter. SPDR S&P Biotech ETF comprises approximately 6.1% of Chiron Capital Management LLC’s holdings, making the stock its 2nd biggest position. Chiron Capital Management LLC owned about 0.12% of SPDR S&P Biotech ETF worth $7,123,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. Compass Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $1,167,000. China Universal Asset Management Co. Ltd. lifted its stake in shares of SPDR S&P Biotech ETF by 868.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after buying an additional 4,411 shares in the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $417,000. Altfest L J & Co. Inc. boosted its holdings in SPDR S&P Biotech ETF by 63.1% in the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after buying an additional 48,326 shares during the period. Finally, Brian Low Financial Group LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter worth $668,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $121.83 on Friday. The stock has a fifty day simple moving average of $125.47 and a two-hundred day simple moving average of $115.18. The firm has a market capitalization of $8.14 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.